Every person living with neurofibromatosis type 1 (NF1) has a story—and nearly all of those stories include cutaneous neurofibromas (cNFs). These benign tumors of the skin may not pose a life-threatening risk, but for the […]
Read More
It can spawn tumors throughout the nervous system and bone deformities that riddle the whole body with pain. One of the most common rare diseases in the world, the genetic condition neurofibromatosis type 1, or NF1, can cause a wide spectrum of mild to severe symptoms—all stemming from a single mutation on a solitary gene: the NF1 gene on chromosome 17.
Read MoreThe first manuscript from the NTAP 2022 Cutaneous Neurofibroma Symposium was published digitally by the Journal of Investigative Dermatology today. The paper RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in […]
Read MoreA forum to identify priorities and advance the field of neurofibromatosis type-1 (NF1) research Introduction to NTAP symposiaNTAP convenes leading researchers and innovators from across multiple fields and scientific backgrounds in regular symposia to establish […]
Read MoreJuly 10, 2018: One of the hallmarks of the complex syndrome Neurofibromatosis type 1 (NF1) are cutaneous neurofibromas (cNF). cNF are tumors involving the skin that affect up to 99 percent of adults with NF1. […]
Read More9 Projects Transforming the Field of NF1 Research NTAP convenes symposiums on a regular basis to determine research priorities, define new avenues of inquiry and develop requests for applications (RFAs) in neurofibromatosis type-1 (NF1) research […]
Read MoreAs a result of the 2018 Cutaneous Neurofibroma Initiative, several working groups were formed to produce papers addressing key challenges identified. Those papers are summarized below with links to the full papers provided. This information […]
Read MoreEstablishing priorities and advancing the field of NF1 research Introduction to NTAP symposiaNTAP convenes leading researchers and innovators from across multiple fields and scientific backgrounds in regular symposia to establish priorities for the future NF1-related […]
Read More